Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Arterra Bioscience SpA ( (IT:ARBS) ) has issued an announcement.
Arterra Bioscience S.p.A. announced its participation in the ‘Reverse Roadshow’ event in Naples, organized by Banca Profilo. This event, taking place on October 2 and 3, provides Arterra an opportunity to showcase its advancements and strengthen its industry positioning. The participation underscores Arterra’s commitment to innovation and collaboration, potentially enhancing its visibility and stakeholder engagement in the biotech sector.
More about Arterra Bioscience SpA
Arterra Bioscience S.p.A. is an Italian green biotech company that focuses on research and development in biotechnology. Listed on the Euronext Growth Milan market since 2019, the company develops enabling technologies and bio-sustainable products for various sectors, including cosmetics, agriculture, and nutraceuticals. Founded in 2004 by Gabriella Colucci, Arterra collaborates with numerous companies and research institutes globally, including a joint venture with Intercos S.p.A. for innovative skincare products.
Average Trading Volume: 16,861
Technical Sentiment Signal: Buy
Current Market Cap: €18.78M
For an in-depth examination of ARBS stock, go to TipRanks’ Overview page.